Global Microcephaly Market – Industry Trends and Forecast to 2029

Microcephaly Market Analysis and Size

The global microcephaly market is expected to witness significant growth during the forecast period.  Rising incidences of neurological disabilities during pregnancy and constant WHO monitoring on countries affected by Zika virus will boost up the microcephaly market. The microcephaly market is majorly driven by rise in prevalence of neurological abnormalities and high diagnostics rate. COVID-19 also had a major impact on the market growth.

 Data Bridge Market Research analyses a growth rate in the global microcephaly market in the forecast period 2022-2029. The expected CAGR of global microcephaly market is tend to be around 8.50% in the mentioned forecast period. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Market Definition

Microcephaly is the rare neurological disorder in which neonates born with small head or head stop growing after birth as compared to the normal neonates or babies. Microcephaly can be present at birth time (congenital) or may develop after the birth (acquired). Moreover, babies born with microcephaly may also suffer from seizures, learning disabilities as they grow older. There is no cure or treatment for the microcephaly but required medical specialties for many disorders such as pediatrics, infectious diseases, neurology, ophthalmology, genetics and psychology.

Global Microcephaly Market Scope and Segmentation

Global Microcephaly Market Dynamics

Drivers

• Increased Cases of Zika Virus

As per the CDC reports in April 2017, it was witnessed that 5,264 people were infected with Zika in the U.S., and it was found that more than 1,700 pregnant women were found Zika-positive and around 58 babies were born having birth defects.  

• Dedicated Initiatives by Multiple Organizations

Several organizations such as WHO, PAHO, and UNICEF step forward in providing response strategies for Zika outbreak. These strategies started from arranging diagnostics to disease treatment. Apart from providing fund for Zika virus disease, the organizations are stepping toward stockpiling diagnostics for emergencies in the future, which in turn is boosting the growth of the market.

Opportunities

• Increasing Demand for Magnetic Resonance Imaging

Among the other diagnostic tests performed for testing Zika virus, magnetic resonance imaging (MRI) is likely to boost the market share, due to increasing number of pregnant women suffering from Zika virus infection and efficacy of magnetic resonance imaging (MRI) in the diagnosis of microcephaly. This creates more opportunity to the market

• Increasing Demand for Retail Pharmacies

Rise in the number of cortical necrosis therapeutics being delivered through retail pharmacies and surge in the number of retail pharmacies in developed countries create opportunities for the market growth. In addition to this, patients prefer retail pharmacies for purchasing drugs, as these are easily accessible.

 Restraints/Challenges

• Lack of skilled professionals

The lack of qualified personnel who are unable to treat the patients with appropriate treatments could curb the growth of the microcephaly market over a forecast period.

• High Cost

The huge expenditure associated with necrosis medications surely hamper the market growth.

This global microcephaly market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global microcephaly market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Microcephaly Market        

Considering the present scenario, COVID-19 has left a major global public health crisis that has impacted practically every business, and its long-term repercussions are expected to have an influence on industry growth during the forecast period. Transition of healthcare infrastructure toward managing COVID-19 has led to drug launch cancellations and delays in clinical trials.

Although during the pandemic, the attention was driven towards the COVID-19 patients majorly and hospitals and clinics were occupied with these patients but in the post-pandemic era, the biotechnology and pharmaceutical industries are expected to witness a huge growth in the future, as research and treatments are drifting again towards the normal patients. Thus, this will leave a significant impact on the global microcephaly market.

Global Microcephaly Market Scope

The global microcephaly market is segmented on the basis of diagnosis, treatment, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Diagnosis

• Ultrasound
• CT Scan
• MRI
• Others

Treatment

• Medication
• Occupational Therapy
• Physical Therapy
• Others

End User

• Hospitals
• Homecare
• Specialty Clinics
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Microcephaly Market Regional Analysis/Insights

The global microcephaly market is analysed and market size insights and trends are provided by diagnosis, treatment, distribution channel and end-user as referenced above.

The major countries covered in the global microcephaly market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America has been witnessing a positive growth for global microcephaly market throughout the forecasted period due to rising prevalence of neonatal neurological disorders

Asia-Pacific dominates the market due to increased WHO & government awareness programs and increased zika virus infection in Asian countries.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Microcephaly Market Share Analysis

The global microcephaly market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global microcephaly market

Key players operating in the global microcephaly market include:

• Merck KGaA (Germany)
• Novartis AG (Switzerland)
• Beckman Coulter Inc. (U.S.)
• bioMerieux (France)
• Bio-Rad Laboratories, Inc (U.S.)
• Danaher (U.S.)
• Hologic (U.S.)
• Inovio Pharmaceuticals (U.S.)
• Lonza (Switzerland)
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Mylan N.V. (U.S.)
• Teva Pharmaceutical Industries Ltd. (Israel)
• Sanofi (France)
• Pfizer Inc. (U.S.)
• GlaxoSmithKline plc (U.K.)

SKU-53816